華上生醫
| 年度/季度 | 每股盈餘 | 上季比較 | 去年同季 | 去年同季比較 |
|---|
| 2025Q4 | -1.22 | -17.31% | -0.95 | -28.42% |
| 2025Q2 | -1.04 | -9.47% | -1.60 | 35.00% |
| 2024Q4 | -0.95 | 40.63% | -0.64 | -48.44% |
| 2024Q2 | -1.60 | -150.00% | -1.04 | -53.85% |
| 2023Q4 | -0.64 | 38.46% | -1.19 | 46.22% |
| 2023Q2 | -1.04 | 12.61% | -1.59 | 34.59% |
| 2022Q4 | -1.19 | 25.16% | -1.59 | 25.16% |
| 2022Q2 | -1.59 | - | -1.38 | -15.22% |
| 2021Q4 | -1.59 | -15.22% | - | - |
| 2021Q2 | -1.38 | - | - | - |
| 年度/季度 | 每股盈餘 | 去年同季 | 去年同季比較 |
|---|
| 2025Q4 | -2.26 | -2.55 | 11.37% |
| 2025Q2 | -1.04 | -1.60 | 35.00% |
| 2024Q4 | -2.55 | -1.68 | -51.79% |
| 2024Q2 | -1.60 | -1.04 | -53.85% |
| 2023Q4 | -1.68 | -2.78 | 39.57% |
| 2023Q2 | -1.04 | -1.59 | 34.59% |
| 2022Q4 | -2.78 | -2.97 | 6.40% |
| 2022Q2 | -1.59 | -1.38 | -15.22% |
| 2021Q4 | -2.97 | -2.80 | -6.07% |
| 2021Q2 | -1.38 | - | - |
| 年度/季度 | 近四季每股盈餘 | 上季比較 | 去年同季比較 |
|---|
| 2025Q4 | -2.26 | -13.57% | 11.37% |
| 2025Q2 | -1.99 | 21.96% | 11.16% |
| 2024Q4 | -2.55 | -13.84% | -51.79% |
| 2024Q2 | -2.24 | -33.33% | -0.45% |
| 2023Q4 | -1.68 | 24.66% | 39.57% |
| 2023Q2 | -2.23 | 19.78% | 29.87% |
| 2022Q4 | -2.78 | 12.58% | 6.40% |
| 2022Q2 | -3.18 | -7.07% | -130.43% |
| 2021Q4 | -2.97 | -115.22% | - |
| 2021Q2 | -1.38 | - | - |
| 年度 | 每股盈餘 | 年增率 |
|---|
| 2025 | -2.26 | 11.37% |
| 2024 | -2.55 | -51.79% |
| 2023 | -1.68 | 39.57% |
| 2022 | -2.78 | 6.40% |
| 2021 | -2.97 | -6.07% |